Invanz and Tricor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Invanz (ertapenem sodium) and Tricor (fenofibrate). Common drug interactions include insomnia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Invanz and Tricor. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Invanz?

Invanz has active ingredients of ertapenem sodium. It is often used in urinary tract infection. eHealthMe is studying from 3,961 Invanz users. Check the latest studies of Invanz.

What is Tricor?

Tricor has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 22,641 Tricor users. Check the latest studies of Tricor.



On Jul, 14, 2026

13 people who take Invanz and Tricor together, and have interactions are studied.

Invanz and Tricor drug interactions.

What are the common drug interactions of Invanz and Tricor, by gender? *:

female:

  1. Insomnia (sleeplessness)
  2. Balance disorder
  3. Hypotension (abnormally low blood pressure)
  4. Neuropathy peripheral (surface nerve damage)
  5. Anxiety
  6. Vertigo
  7. Constipation
  8. Dizziness
  9. Dyspnoea (difficult or laboured respiration)
  10. Fatigue (feeling of tiredness)

male:

  1. Asthenia (weakness)
  2. Blood calcium increased
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Hypertension (high blood pressure)
  5. Impaired fasting glucose
  6. Obesity (having too much body fat)
  7. Osteomyelitis (infection of bone)
  8. Staphylococcal infection (an infection with staphylococcus bacteria)
  9. Type 2 diabetes mellitus
  10. Confusional state

What are the common drug interactions of Invanz and Tricor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)

60+:

  1. Asthenia (weakness)
  2. Blood calcium increased
  3. Diplopia (double vision)
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Fatigue (feeling of tiredness)
  7. Hemiparesis (weakness on one side of the body)
  8. Hyperlipidaemia (presence of excess lipids in the blood)
  9. Hypertension (high blood pressure)
  10. Impaired fasting glucose

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 8 people, 61.54%
  2. Infection: 2 people, 15.38%
  3. Osteomyelitis (infection of bone): 1 person, 7.69%
  4. Analgesia: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Invanz and Tricor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Invanz and Tricor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Invanz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tricor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Invanz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tricor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ertapenem sodium and fenofibrate (the active ingredients of Invanz and Tricor, respectively), and Invanz and Tricor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: